
Apellis Pharmaceuticals, Inc. (APLS) - Yahoo Finance
Find the latest Apellis Pharmaceuticals, Inc. (APLS) stock quote, history, news and other vital information to help you with your stock trading and investing.
APLS Stock Price | Apellis Pharmaceuticals Inc ... - MarketWatch
3 days ago · Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic …
APLS: Apellis Pharmaceuticals Inc - Stock Price, Quote and ...
Get Apellis Pharmaceuticals Inc (APLS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Apellis Pharmaceuticals (APLS) Stock Price & Overview
1 day ago · A detailed overview of Apellis Pharmaceuticals, Inc. (APLS) stock, including real-time price, chart, key statistics, news, and more.
Apellis Pharmaceuticals Inc (APLS) Stock Price & News ...
Get the latest Apellis Pharmaceuticals Inc (APLS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
APLS | Apellis Pharmaceuticals Inc. Stock Overview (U.S ...
2 days ago · Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic …
Official Home Page of the Apellis Pharmaceuticals Corporate ...
Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive …
Apellis Pharmaceuticals - APLS - Stock Price Today - Zacks
4 days ago · Get the latest Apellis Pharmaceuticals, Inc APLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Antiphospholipid syndrome - Symptoms & causes - Mayo Clinic
Sep 19, 2025 · Antiphospholipid (AN-te-fos-fo-LIP-id) syndrome is a condition in which the immune system mistakenly makes antibodies that attack tissues in the body. These antibodies …
Stifel maintains Apellis Pharmaceuticals (APLS) buy ... - MSN
Dec 19, 2025 · Fintel reports that on December 19, 2025, Stifel maintained coverage of Apellis Pharmaceuticals (NasdaqGS:APLS) with a Buy recommendation. Analyst Price Forecast …